Literature DB >> 9923912

Drop-outs in tamoxifen prevention trials.

U Veronesi, P Maisonneuve, A Costa, N Rotmensz, P Boyle.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 9923912     DOI： 10.1016/S0140-6736(05)77261-5

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  1 in total

1.  Acceptability of cancer chemoprevention trials: impact of the design.

Authors:  Anne-Sophie Maisonneuve; Laetitia Huiart; Laetitia Rabayrol; Doug Horsman; Remi Didelot; Hagay Sobol; Francois Eisinger
Journal:  Int J Med Sci       Date:  2008-08-22       Impact factor: 3.738
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.